Deciphera Pharmaceuticals (DCPH) Stock Forecast for 2023 – 2026. Sell or Buy?
Updated: December 3, 2023 (06:40)
Sector: HealthcareThe share price of Deciphera Pharmaceuticals, Inc. (DCPH) now
50/200 Day Moving Average: $11.86 / $13.77
This figure corresponds to the Average Price over the previous 50/200 days. For Deciphera Pharmaceuticals stocks, the 50-day moving average is the support level today.
For Deciphera Pharmaceuticals stocks, the 200-day moving average is the resistance level today.
Are you interested in Deciphera Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Deciphera Pharmaceuticals stock price in 2023, 2024, 2025, 2026, 2027. How much will one Deciphera Pharmaceuticals share be worth in 2023 - 2027?
When should I take profit in Deciphera Pharmaceuticals stock? When should I record a loss on Deciphera Pharmaceuticals stock? What are analysts' forecasts for Deciphera Pharmaceuticals stock? What is the future of Deciphera Pharmaceuticals stock? We forecast Deciphera Pharmaceuticals stock performance using neural networks based on historical data on Deciphera Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Deciphera Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Deciphera Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of Deciphera Pharmaceuticals stock
The chart below shows the historical price of Deciphera Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Deciphera Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
Deciphera Pharmaceuticals, Inc. is a clinical research biopharmaceutical company.
The company develops drugs designed to improve the lives of cancer patients. Her drug candidates include DCC-2618, DCC-3014 and (Rebastinib) Rebastinib. The platform of kinase switching inhibitors developed by the Company suppresses the process of kinase activation. DCC-2618 is an orally administered inhibitor of kinase switching control for the treatment of gastrointestinal stromal tumors (GIST), advanced systemic mastocytosis (ASM), gliomas including glioblastoma multiforme (GBM), and other solid tumors caused by the pan-KIT or PDGFR gene alpha. DCC-3014 is an orally administered potent and highly selective colony stimulating factor receptor 1 (CSF1R) inhibitor. Rebastinib is a potent and selective oral immunokinase inhibitor of TIE2. Rebastinib binds tightly to the binding region (pocket) of the TIE2 switch, stabilizing the inhibitory switch and displacing the activation switch to block TIE2 signaling.
Deciphera Pharmaceuticals daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec 05 | 13.89 | 13.30 | 14.14 | 6.32 |
| Dec 06 | 13.87 | 13.54 | 14.15 | 4.51 |
| Dec 07 | 13.85 | 13.45 | 14.31 | 6.40 |
| Dec 08 | 13.47 | 13.00 | 13.83 | 6.38 |
| Dec 09 | 13.60 | 13.13 | 14.09 | 7.29 |
| Dec 10 | 14.35 | 14.17 | 14.89 | 5.07 |
| Dec 11 | 14.33 | 14.13 | 14.78 | 4.63 |
| Dec 12 | 14.70 | 14.40 | 14.96 | 3.87 |
| Dec 13 | 15.31 | 14.99 | 15.80 | 5.39 |
| Dec 14 | 15.29 | 14.75 | 15.71 | 6.50 |
| Dec 15 | 15.21 | 14.97 | 15.75 | 5.25 |
| Dec 16 | 15.79 | 15.34 | 16.00 | 4.30 |
| Dec 17 | 15.60 | 15.10 | 16.00 | 5.97 |
| Dec 18 | 15.30 | 14.81 | 15.49 | 4.60 |
| Dec 19 | 15.45 | 15.28 | 15.86 | 3.84 |
| Dec 20 | 16.13 | 15.73 | 16.58 | 5.41 |
| Dec 21 | 16.93 | 16.60 | 17.13 | 3.20 |
| Dec 22 | 16.61 | 16.04 | 16.98 | 5.86 |
| Dec 23 | 16.76 | 16.37 | 17.02 | 4.00 |
| Dec 24 | 16.04 | 15.62 | 16.48 | 5.54 |
| Dec 25 | 15.95 | 15.34 | 16.14 | 5.20 |
| Dec 26 | 15.24 | 14.88 | 15.86 | 6.53 |
| Dec 27 | 15.58 | 15.34 | 15.89 | 3.58 |
| Dec 28 | 15.53 | 15.35 | 16.11 | 4.95 |
| Dec 29 | 16.01 | 15.39 | 16.41 | 6.64 |
| Dec 30 | 16.25 | 15.97 | 16.66 | 4.37 |
| Dec 31 | 15.96 | 15.68 | 16.25 | 3.64 |
| Jan 01 | 15.57 | 15.24 | 15.89 | 4.27 |
| Jan 02 | 15.31 | 14.80 | 15.98 | 7.97 |
| Jan 03 | 15.30 | 14.77 | 15.79 | 6.89 |
Deciphera Pharmaceuticals Daily Price Targets
Deciphera Pharmaceuticals Stock Forecast 12-05-2023.
Forecast target price for 12-05-2023: $13.89.
Positive dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 5.942%.
Pessimistic target level: 13.30
Optimistic target level: 14.14
Deciphera Pharmaceuticals Stock Forecast 12-06-2023.
Forecast target price for 12-06-2023: $13.87.
Negative dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 4.312%.
Pessimistic target level: 13.54
Optimistic target level: 14.15
Deciphera Pharmaceuticals Stock Forecast 12-07-2023.
Forecast target price for 12-07-2023: $13.85.
Negative dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 6.014%.
Pessimistic target level: 13.45
Optimistic target level: 14.31
Deciphera Pharmaceuticals Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $13.47.
Negative dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 5.999%.
Pessimistic target level: 13.00
Optimistic target level: 13.83
Deciphera Pharmaceuticals Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $13.60.
Positive dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 6.797%.
Pessimistic target level: 13.13
Optimistic target level: 14.09
Deciphera Pharmaceuticals Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $14.35.
Positive dynamics for Deciphera Pharmaceuticals shares will prevail with possible volatility of 4.822%.
Pessimistic target level: 14.17
Optimistic target level: 14.89
DCPH (DCPH) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec. | 11.21 | 9.53 | 12.85 | 25.83 |
Deciphera Pharmaceuticals forecast for this year
Deciphera Pharmaceuticals Stock Prediction for Dec 2023
An downtrend is forecast for this month with an optimal target price of $11.2118. Pessimistic: $9.53. Optimistic: $12.85
Deciphera Pharmaceuticals (DCPH) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 10.63 | 10.20 | 11.65 | 12.41 |
| Feb | 10.33 | 9.65 | 11.47 | 15.86 |
| Mar | 10.91 | 9.73 | 12.52 | 22.30 |
| Apr | 10.12 | 8.79 | 10.93 | 19.63 |
| May | 11.26 | 9.75 | 12.23 | 20.26 |
| Jun | 13.28 | 12.65 | 13.87 | 8.81 |
| Jul | 14.32 | 12.43 | 16.35 | 23.99 |
| Aug | 13.15 | 12.04 | 13.78 | 12.60 |
| Sep | 11.70 | 9.92 | 12.82 | 22.63 |
| Oct | 12.38 | 10.92 | 14.11 | 22.63 |
| Nov | 10.79 | 9.35 | 11.40 | 17.99 |
| Dec | 10.58 | 8.95 | 12.25 | 26.94 |
Deciphera Pharmaceuticals (DCPH) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 10.81 | 9.10 | 12.15 | 25.09 |
| Feb | 12.11 | 10.56 | 12.98 | 18.66 |
| Mar | 13.34 | 12.65 | 14.52 | 12.87 |
| Apr | 15.35 | 13.72 | 16.02 | 14.37 |
| May | 17.89 | 15.64 | 20.25 | 22.79 |
| Jun | 20.11 | 19.19 | 22.57 | 14.97 |
| Jul | 21.88 | 19.87 | 25.08 | 20.77 |
| Aug | 23.02 | 20.35 | 24.22 | 15.97 |
| Sep | 22.97 | 19.44 | 24.67 | 21.23 |
| Oct | 22.88 | 20.27 | 25.99 | 22.01 |
| Nov | 25.03 | 23.63 | 26.08 | 9.40 |
| Dec | 27.03 | 23.14 | 30.17 | 23.30 |
Deciphera Pharmaceuticals (DCPH) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 25.03 | 22.43 | 26.34 | 14.83 |
| Feb | 28.69 | 25.71 | 30.41 | 15.47 |
| Mar | 23.07 | 19.56 | 26.16 | 25.22 |
| Apr | 22.88 | 21.97 | 24.12 | 8.92 |
| May | 20.09 | 18.16 | 22.02 | 17.52 |
| Jun | 18.16 | 16.05 | 19.76 | 18.75 |
| Jul | 16.53 | 14.58 | 17.85 | 18.33 |
| Aug | 14.97 | 12.64 | 17.10 | 26.09 |
| Sep | 16.47 | 15.25 | 18.12 | 15.82 |
| Oct | 17.69 | 14.86 | 18.68 | 20.45 |
| Nov | 19.39 | 18.19 | 21.02 | 13.47 |
| Dec | 19.39 | 18.34 | 20.28 | 9.56 |
Deciphera Pharmaceuticals (DCPH) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 21.52 | 20.14 | 24.75 | 18.61 |
| Feb | 22.47 | 21.52 | 25.79 | 16.55 |
| Mar | 20.31 | 19.46 | 22.83 | 14.77 |
| Apr | 20.47 | 19.24 | 22.77 | 15.47 |
| May | 19.04 | 17.86 | 19.80 | 9.81 |
| Jun | 19.27 | 16.26 | 21.00 | 22.57 |
| Jul | 20.15 | 17.25 | 21.85 | 21.03 |
| Aug | 20.76 | 19.72 | 22.17 | 11.05 |
| Sep | 23.25 | 21.25 | 25.85 | 17.81 |
| Oct | 24.55 | 23.42 | 26.32 | 11.01 |
| Nov | 23.52 | 19.90 | 25.83 | 22.95 |
| Dec | 24.84 | 22.30 | 26.18 | 14.80 |
Deciphera Pharmaceuticals information and performance
200 SMITH STREET, WALTHAM, MA, US
Market capitalization of the Deciphera Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of DCPH shares in the company outstanding by the market price of one share.
EBITDA of Deciphera Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
